Remimazolam

Chemical formula: C₂₁H₁₉BrN₄O₂ Molecular mass: 439.313 g/mol PubChem compound: 9867812

Therapeutic indications

Remimazolam is indicated for:

Procedural sedation

Population group: only adults (18 years old or older)

Sedation

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Induction dose of 5 mg following administration of opioids or 7 mg without opioid, over 1 min, and after 2 min maintenance dose of 2.5 mg over 15 sec

Induction dose of 2.5-5 mg over 1 min, and after 2 min maintenance dose of 1.25-2.5 mg over 15 sec

Contraindications

Remimazolam is contraindicated in the following cases:

Lactation

Effects on ability to drive and use machines

Unstable myasthenia gravis

Myasthenia gravis

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.